In this sense, a recent meta-analysis showed that insulin icodec was associated with significantly decreased HbA1C, an increased time with glucose in range and similar hypoglycemic and severe adverse effects compared with long-acting insulin in people with T2DM [68]. The gene discussed is INS; the disease is type 2 diabetes mellitus.